Cargando…
At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: Learnings from a population based study
INTRODUCTION: It is critical to assess who is being treated with a new marketed drug like esketamine to understand how it is used in the real‐world setting and the effects of the medication. METHODS: Retrospective analysis using two large U.S. health care databases that included commercially insured...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248018/ https://www.ncbi.nlm.nih.gov/pubmed/33475213 http://dx.doi.org/10.1002/da.23138 |